Advertisement

Stock in Danvers-based Abiomed Inc. (Nasdaq: ABMD) plummeted 30 percent to $13.83 as of noon Thursday after the company disclosed that it’s been subpoenaed by the U.S. Attorney’s Office related to an investigation into its labeling and marketing of its Impella 2.5 heart pump.

Advertisement
Advertisement